DeHeng Advised Vivest Medical on Completing

the Series A Financing Close to RMB 100 Million

2021-05-14

Suzhou Vivest Medical Technology Co., Ltd. has recently completed its series A financing and raised close to RMB 100 million from the lead investor Northern Light Venture Capital, and co-investors Bohua Capital and Blue Sail Medical.

As the legal counsel for the lead investor, the DeHeng team, with primary support from Zhang Lei, Zhu Yun and Shang Shuaili, participated in the due diligence, document drafting, negotiation, closing and other follow-up matters of the transaction. The team worked closely, professionally and efficiently to close the deal, and won the trust and recognition from the client and other parties involved. With a focus on emerging industries such as biomedicine, artificial intelligence, big data, TMT and top-tier manufacturing, DeHeng lawyers will leverage their rich project experience and industry resources accumulated over the years, and the ability to conduct swift, insightful research, to continuously provide high-quality legal services to our clients.